Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations

Canadian Journal of Physiology and Pharmacology

Volumn 79, Issue 10, 2001, Pages 841-847

  Gaedigk, A ^a   Casley, W L ^a   Tyndale, R F ^a   Sellers, E M ^a   Jurima Romet, M ^a   Leeder, J S ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

CYP2C9; Ethnic diversity; Genotyping; Polymorphism

Indexed keywords

CYTOCHROME P450 2C9;

ALLELE; ARTICLE; CANADA; CAUCASIAN; CHINESE; DNA POLYMORPHISM; ETHNIC GROUP; GENE FREQUENCY; GENOTYPE; HUMAN; INDIAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0034762014     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y01-065     Document Type: Article

References (34)

1. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
2. Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin
3. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population
4. Genetic analysis of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjects
5. Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African-Americans
6. NADP(H):quinone oxido-reductase: Polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations
7. Biochemistry and molecular biology of the human CYP2C subfamily
8. Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations
9. Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: Genetic analysis of the CYP2C9 locus
10. CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population
11. CYP2D6-related oxidation polymorphism in a Canadian Inuit population
12. Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele
13. Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population
14. Determinants of warfarin S:R ratio in orthopedic surgery
15. Lung cancer risk in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles County
16. Genetic markers in blood in a Canadian Eskimo population with a comparison of allele frequencies in circumpolar populations
17. Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174
18. Cytochrome P4502C9: An enzyme of major importance in human drug metabolism
19. Genetic analysis of CYP2C9 polimorphism in a Japanese population
20. CYP2D6 phenotype and genotype in a Canadian Native Indian Population
21. Canadian Native Indians exhibit unique CYP2A6 and CYP2C19 mutant allele frequencies
22. Immunoglobulin allotypes indicate multiple founding populations of Native Americans: Evidence of at least four migrations to the new world
23. Genetic association between sensitivity to warfarin and expression of CYP2C9*3
24. Genetic analysis of the human cytochrome P4502C9 locus
25. 359 allelic variant in the tolbutamide polymorphism
26. Peopling of northern North America: Clues from genetic studies
27. Asian affinities and continental radiation of the four founding Native American mtDNAs
28. mtDNA variation of aboriginal Siberians reveals distinct genetic affinities with native Americans
29. Mitochondrial DNA "clock" for the Amerinds and its implications for timing their entry into North America
30. Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese
31. American origins
32. Validation of methods for CYP2C9 genotyping: Frequencies of mutant alleles in a Swedish population
33. Frequency of cytochrome P450 2C9 mutant alleles in a Korean population